Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 14, 2019

SELL
$151.91 - $192.21 $1.05 Million - $1.33 Million
-6,920 Closed
0 $0
Q3 2018

Oct 03, 2018

SELL
$167.73 - $192.74 $104,831 - $120,462
-625 Reduced 8.28%
6,920 $1.18 Million
Q2 2018

Jul 05, 2018

SELL
$145.72 - $169.96 $180,109 - $210,070
-1,236 Reduced 14.08%
7,545 $1.28 Million
Q1 2018

Apr 13, 2018

BUY
$151.6 - $177.13 $1.33 Million - $1.56 Million
8,781 New
8,781 $1.43 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $128B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Verde Servicos Internacionais S.A. Portfolio

Follow Verde Servicos Internacionais S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verde Servicos Internacionais S.A., based on Form 13F filings with the SEC.

News

Stay updated on Verde Servicos Internacionais S.A. with notifications on news.